Berberine Hydrochloride (CAS Number: 633-65-8; Molecular Formula: C20H18ClNO4•xH2O, predominantly dihydrate) is a quaternary isoquinoline alkaloid of paramount pharmacological importance. As the worldwide demand for natural metabolic regulators surges, international supplement brands, contract manufacturers (CMOs), and pharmaceutical distributors seek verified, bulk-scale Chinese chemical manufacturers and primary botanical extractors capable of delivering sustained compendial compliance according to USP (United States Pharmacopeia), EP (European Pharmacopoeia), and CP (Chinese Pharmacopoeia) specifications.
In China, primary industrial manufacturing of bulk Berberine HCL is anchored predominantly in the wild harvesting and standardized agricultural cultivation of Phellodendron amurense Rupr. bark (Amur Corktree / Cortex Phellodendri), Phellodendron chinense Schneid, and regional berberis variants such as Berberis aristata and Rhizoma Coptidis (Coptis chinensis). Sustainable bark-stripping and managed forestry protocols in Sichuan, Shaanxi, and Yunnan provide direct raw material security, insulating high-volume international buyers from periodic raw-herb scarcity.
The industrial extraction workflow utilizes multi-stage aqueous-ethanolic percolations under regulated thermal parameters (55°C to 65°C) to prevent thermal degradation of the quaternary ammonium nucleus. Following crude concentration, the extract liquor undergoes acidic salt precipitation via dilute hydrochloric acid (HCl), yielding raw berberine chloride precipitates. Subsequent recrystallization cycles in pharmaceutical-grade closed crystallization reactors eliminate associated secondary alkaloids (such as jateorhizine, palmatine, and magnoflorine), achieving a minimum chromatographic assay of 97.0% up to 99.2% Berberine HCL calculated on an anhydrous basis.
For B2B QA directors and formulating scientists, procurement risks hinge on strict adherence to target market regulatory frameworks. The table below outlines the core parameters evaluated prior to lot release:
| Analytical Test Parameter | USP-NF Compendial Criterion | EP / BP Pharmacopeial Target | Analytical Methodology |
|---|---|---|---|
| Assay (Anhydrous Basis) | 97.0% – 102.0% Berberine HCL | 98.0% – 101.5% | Reversed-Phase HPLC (UV @ 345 nm) |
| Identification (A & B) | Conforms to Reference Standard | Conforms to Reference Standard | TLC & Infrared Spectrophotometry (FTIR) |
| Related Alkaloids / Impurities | Individual ≤ 1.0%; Total ≤ 2.0% | Palmatine ≤ 0.5%; Total ≤ 1.5% | High-Performance Liquid Chromatography |
| Loss on Drying (LOD) | ≤ 12.0% | ≤ 12.5% | Vacuum Desiccation (105°C to constant mass) |
| Residue on Ignition (Sulfated Ash) | ≤ 0.2% | ≤ 0.1% | Gravimetric Muffle Furnace (600°C) |
| Heavy Metal Speciation | Pb ≤ 0.5ppm, As ≤ 1.0ppm, Cd ≤ 0.5ppm | EP 2.4.27 Compliant Limits | Inductively Coupled Plasma Mass Spectrometry (ICP-MS) |
Formulation speed and tableting consistency represent significant overhead costs for supplement contract packers. Standard precipitated Berberine HCL exhibits needle-like (acicular) crystal morphology that can impede mass powder flow in high-speed rotary tablet presses and automatic encapsulators, occasionally leading to weight variance and capping. As an experienced exporter, we supply engineered particle sizing: standard 80-mesh powder, pre-granulated DC (Direct Compressible) grades compounded with non-GMO excipients, and micronized options (D90 < 15 μm) explicitly optimized for liposomal or phospholipid bioavailability enhancement technologies.
Scientific validation demonstrating Berberine HCL's activation of AMP-activated protein kinase (AMPK) and stimulation of proglucagon-derived GLP-1 secretion has ignited a massive consumer demand shift. Global procurement teams are establishing long-term index-linked contracts to lock in pricing and volume reserves, avoiding the spot-market volatility that accompanied previous viral dietary trends.
Native Berberine HCL exhibits modest intestinal absorption (∼5%) due to P-glycoprotein efflux pump activity. The market is accelerating rapidly toward advanced delivery technologies: phospholipid phytosomes, sodium caprate/cyclodextrin conjugates, and Dihydroberberine (DHB). Importers are actively sourcing higher-bulk-density raw powders that readily integrate into proprietary wet-granulation and liposomal processing platforms.
With authorities such as the US FDA, Health Canada, and European EFSA enforcing lower microgram-per-day thresholds for inorganic arsenic, cadmium, and lead in plant extracts, standard wholesale lots are increasingly rejected at ports of entry. Forward-thinking manufacturers are sourcing exclusively from facilities with dedicated closed-loop ion-exchange purification systems that guarantee Pb < 0.2 ppm.
Export compliance to Europe now requires stringent environmental footprints. Chinese facilities operating closed-cycle ethanol condensation recovery systems (≥95% solvent reclaim rate) and renewable energy extraction boilers are displacing inefficient coal-dependent operators, ensuring brand partners avoid impending carbon-tariff penalties and satisfy corporate ESG directives.
Adulteration of premium Phellodendron or Coptis origins with generic non-standardized chemical syntheses is increasingly targeted by third-party brand auditors. Future wholesale supply agreements mandate independent genomic (DNA barcoding) and HPTLC fingerprint identification to safeguard against species adulteration and maintain label claim authenticity.
International contract manufacturing organizations are moving away from single-batch spot purchases toward strategic inventory partnerships. Consignment hubs and bonded warehouse reserves in Europe and North America, supported by direct Chinese factory production schedules, allow brands to guarantee 48-hour ingredient replenishment and zero assembly-line downtime.
Produced under certified cGMP, ISO 9001, and ISO 22000 quality systems, supported by valid Halal, Kosher, and non-GMO production certificates renewed and verified annually.
Every commercial lot ships accompanied by a comprehensive batch CoA, technical specification sheet, Safety Data Sheet (SDS), and certified residual solvent and microbiological clearance.
Seamless international logistics covering CIF, FOB, and DDP terms with expert clearance handling for customs, FDA prior notice, phytosanitary certificates, and European port entries.
From standard 80-mesh powders to ultra-fine micronized grades (D90 < 15 μm) and direct compression (DC) granules designed to maximize machine yields and prevent tablet friability.
Our standard pharmaceutical-grade commercial export lots are specified at ≥ 97.0% up to 99.0% Berberine HCL, determined via isocratic Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) calculated on an anhydrous basis. Every lot matches or exceeds USP-NF and EP monographs, verifying both total potency and individual related alkaloid thresholds.
We perform High-Performance Thin-Layer Chromatography (HPTLC) fingerprinting cross-referenced against authentic botanical vouchers of Phellodendron amurense bark and Coptis chinensis. For clients requiring forensic verification, we provide third-party Accelerator Mass Spectrometry (AMS) radiocarbon ¹&sup4;C testing to guarantee 100% bio-based botanical carbon content.
Our primary extraction utilizes only food-grade ethanol and purified deionized water. Dilute hydrochloric acid is applied strictly during crystallization. We do not use Class 1 toxic solvents (e.g., benzene, carbon tetrachloride). Class 2/3 residual solvents such as ethanol and methanol are monitored via Headspace Gas Chromatography (GC-HS) and maintained well below ICH Q3C limits (≤ 5,000 ppm for ethanol; ≤ 3,000 ppm for methanol).
Yes. In addition to standard 80-mesh powder (ideal for wet granulation), we produce specialized micronized grades (D50 < 5 μm, D90 < 15 μm) engineered for liposomal formulations, as well as high-tap-density, free-flowing granular grades specifically tailored for direct-compression tableting machines without requiring excessive binder excipients.
Every commercial consignment includes a lot-specific Certificate of Analysis (CoA), Technical Specification Sheet, Safety Data Sheet (SDS), Packing List, Commercial Invoice, Certificate of Origin (COO), and formal statements verifying Non-GMO, BSE/TSE-Free status, Allergen absence, and non-irradiation (unless sterilization is expressly requested).
Our standard export packaging is 25 kg fiber drums with double-sealed food-grade polyethylene interior liners, tamper-evident outer locks, and silica desiccant pouches. MOQ begins at 25 kg for commercial validation lots, with full container-load (FCL) capability. The verified retest period/shelf life is 24 to 36 months when stored in sealed, light-resistant containers away from direct heat and moisture.
